ARAY
Price
$0.76
Change
+$0.01 (+1.33%)
Updated
Feb 4 closing price
Capitalization
85.75M
90 days until earnings call
Intraday BUY SELL Signals
XAIR
Price
$1.09
Change
-$0.06 (-5.22%)
Updated
Feb 4 closing price
Capitalization
11.48M
Intraday BUY SELL Signals
Interact to see
Advertisement

ARAY vs XAIR

Header iconARAY vs XAIR Comparison
Open Charts ARAY vs XAIRBanner chart's image
Accuray
Price$0.76
Change+$0.01 (+1.33%)
Volume$1.11M
Capitalization85.75M
Beyond Air
Price$1.09
Change-$0.06 (-5.22%)
Volume$169.57K
Capitalization11.48M
ARAY vs XAIR Comparison Chart in %
View a ticker or compare two or three
VS
ARAY vs. XAIR commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAY is a Hold and XAIR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (ARAY: $0.76 vs. XAIR: $1.09)
Brand notoriety: ARAY and XAIR are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ARAY: 114% vs. XAIR: 2%
Market capitalization -- ARAY: $85.75M vs. XAIR: $11.48M
ARAY [@Medical/Nursing Services] is valued at $85.75M. XAIR’s [@Medical/Nursing Services] market capitalization is $11.48M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $188.15B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARAY’s FA Score shows that 0 FA rating(s) are green whileXAIR’s FA Score has 1 green FA rating(s).

  • ARAY’s FA Score: 0 green, 5 red.
  • XAIR’s FA Score: 1 green, 4 red.
According to our system of comparison, XAIR is a better buy in the long-term than ARAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARAY’s TA Score shows that 5 TA indicator(s) are bullish while XAIR’s TA Score has 3 bullish TA indicator(s).

  • ARAY’s TA Score: 5 bullish, 2 bearish.
  • XAIR’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ARAY is a better buy in the short-term than XAIR.

Price Growth

ARAY (@Medical/Nursing Services) experienced а -4.61% price change this week, while XAIR (@Medical/Nursing Services) price change was -14.17% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -3.25%. For the same industry, the average monthly price growth was -0.64%, and the average quarterly price growth was +13.10%.

Reported Earning Dates

ARAY is expected to report earnings on May 06, 2026.

Industries' Descriptions

@Medical/Nursing Services (-3.25% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARAY($85.8M) has a higher market cap than XAIR($11.5M). XAIR YTD gains are higher at: 50.138 vs. ARAY (-8.246). ARAY has higher annual earnings (EBITDA): 7.67M vs. XAIR (-31.78M). ARAY has more cash in the bank: 63.3M vs. XAIR (10.7M). XAIR has less debt than ARAY: XAIR (13.9M) vs ARAY (179M). ARAY has higher revenues than XAIR: ARAY (451M) vs XAIR (5.8M).
ARAYXAIRARAY / XAIR
Capitalization85.8M11.5M746%
EBITDA7.67M-31.78M-24%
Gain YTD-8.24650.138-16%
P/E RatioN/AN/A-
Revenue451M5.8M7,773%
Total Cash63.3M10.7M592%
Total Debt179M13.9M1,288%
FUNDAMENTALS RATINGS
ARAY vs XAIR: Fundamental Ratings
ARAY
XAIR
OUTLOOK RATING
1..100
593
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
9164
P/E GROWTH RATING
1..100
47100
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XAIR's Valuation (29) in the null industry is somewhat better than the same rating for ARAY (84) in the Medical Specialties industry. This means that XAIR’s stock grew somewhat faster than ARAY’s over the last 12 months.

XAIR's Profit vs Risk Rating (100) in the null industry is in the same range as ARAY (100) in the Medical Specialties industry. This means that XAIR’s stock grew similarly to ARAY’s over the last 12 months.

ARAY's SMR Rating (97) in the Medical Specialties industry is in the same range as XAIR (100) in the null industry. This means that ARAY’s stock grew similarly to XAIR’s over the last 12 months.

XAIR's Price Growth Rating (64) in the null industry is in the same range as ARAY (91) in the Medical Specialties industry. This means that XAIR’s stock grew similarly to ARAY’s over the last 12 months.

ARAY's P/E Growth Rating (47) in the Medical Specialties industry is somewhat better than the same rating for XAIR (100) in the null industry. This means that ARAY’s stock grew somewhat faster than XAIR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARAYXAIR
RSI
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
73%
Bullish Trend 29 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ARAY
Daily Signal:
Gain/Loss:
XAIR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MCCK63.001.00
+1.61%
Mestek, Inc.
NCBDF25.68N/A
N/A
Bandai Namco Holdings, Inc.
AFRAF12.82N/A
N/A
Air France-KLM
ALOD0.25N/A
N/A
Allied Resources, Inc.
GNGXF0.28N/A
-1.32%
Inventus Mining Corp.

ARAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARAY has been closely correlated with CLPT. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARAY jumps, then CLPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARAY
1D Price
Change %
ARAY100%
+0.65%
CLPT - ARAY
66%
Closely correlated
-4.52%
ITGR - ARAY
64%
Loosely correlated
-0.60%
NNOX - ARAY
60%
Loosely correlated
-5.10%
TELA - ARAY
52%
Loosely correlated
-3.64%
NXL - ARAY
52%
Loosely correlated
-0.16%
More

XAIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XAIR has been loosely correlated with ARAY. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if XAIR jumps, then ARAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XAIR
1D Price
Change %
XAIR100%
-5.22%
ARAY - XAIR
50%
Loosely correlated
+0.65%
ENOV - XAIR
43%
Loosely correlated
+4.68%
CLPT - XAIR
41%
Loosely correlated
-4.52%
NNOX - XAIR
41%
Loosely correlated
-5.10%
NXL - XAIR
41%
Loosely correlated
-0.16%
More